Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist" is generating significant coverage in the Business category, with 6 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Yahoo Finance, Trefis, Seeking Alpha and Investing.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 9h ago.
Quick answers
Why is "Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist" trending?
Because 5 independent news sources published 6 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (10)
- Iovance plummets on new phase 2 Amtagvi data for non-small-cell lung cancer Seeking Alpha · 7h ago
- Melanoma Trial Results Could Be A Game Changer For Iovance Biotherapeutics (IOVA) Yahoo Finance · 7h ago
- Why Did IOVA Stock Jump Over 10% After-Hours Today? TradingView · 10h ago
- Why Did IOVA Stock Jump Over 10% After-Hours Today? Yahoo Finance · 10h ago
- Iovance stock falls after lung cancer trial data disappoints Yahoo Finance · 10h ago
- Can Iovance Stock Fall 50%? Trefis · 10h ago
- Iovance sees long-term response for Amtagvi in first-line melanoma (IOVA:NASDAQ) Seeking Alpha · 10h ago
- Why is Iovance Biotherapeutics stock sliding today? Investing.com · 10h ago
- IOVA Stock Heads For Worst Day In Over 17 Months, Retail Says ‘Selling Is Not Done’ Yahoo Finance · 10h ago
- Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist Investor's Business Daily · 10h ago
Topics
Related trends
Amazon Stock Drops on Wall Street Miss, Despite Biggest Cloud Growth in Years
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Stock Market Today: Dow, S&P 500 and Nasdaq close lower for first time in 4 days, but most stocks rise
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Intel Stock Enters Earnings With a ‘Strong’ Setup, Analysts Say
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Here’s How Much Intel Stock Is Expected to Move After Earnings
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Crocs Stock Spikes 25%. Its Biggest Headache Just Became an Asset.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Stock Market Today: Nasdaq Sinks 350 Points; Google Stock's Tumble in Focus
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.